48.有關氣喘病人的用藥指導,下列敘述何者錯誤?
(A)AeroChamber®有flow indicator whistle,吸太快會有聲響警告
(B)Flexhaler ®須急速吸入(理想情況下 60 L/min)
(C)QVAR Redihaler ®不須使用valved holding chamber
(D)Ellipta ®不須深深吸入(deep inhalation)
統計: A(93), B(114), C(97), D(1228), E(0) #3378629
詳解 (共 10 筆)



56.有關Anoro® Ellipta®(umeclidinium+vilanterol)之用藥指導,下列敘述何者正確?
(A) 此藥品含有corticosteroid,用畢後須漱口
(B) 此藥品使用前須振搖,以利藥品均勻分布
(C) 使用此藥品須用嘴含住吹嘴,快速用力吸入藥品>慢而深吸入
(D) 此藥品可能有心跳加速之副作用>vilanterol為beta2 agonist,使K下降,心跳加速,手抖
專技 - 調劑學與臨床藥學#3221 -112年 - 112-2 專技高考_藥師(二):調劑學與臨床藥學#115864
答案:D
QVAR® RediHaler™ differs from conventional metered-dose inhalers (MDIs) as it delivers medication via a breath-actuated MDI, eliminating the need for hand-breath coordination during inhalation. QVAR® RediHaler™ administers the same active drug ingredient found in QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol, with a different mode of delivery. In addition, QVAR® RediHaler™ is designed to be used without shaking or priming. It should not be used with a spacer or volume holding chamber.